EUVIMEDEUVIMED entdecken
Crossref

Concurrent Capecitabine and Radiation Therapy for High-risk Primary Breast Cancer

Uma Goyal, Tijana Skrepnik, Rajayogesh Davuluri, Michele B Ley, Pavani Chalasani, Rebecca K Viscusi, Lauren G Lebeau, Robert B Livingston, Justin Famoso, Victor J Gonzalez

Oncomedicine · 2017

DOI: 10.7150/oncm.17910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Uma Goyal und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Goyal, U., Skrepnik, T., Davuluri, R., Ley, M. B., Chalasani, P., Viscusi, R. K., Lebeau, L. G., Livingston, R. B., Famoso, J., & Gonzalez, V. J. (2017). Concurrent Capecitabine and Radiation Therapy for High-risk Primary Breast Cancer. Oncomedicine. https://doi.org/10.7150/oncm.17910

Vancouver

Goyal U, Skrepnik T, Davuluri R, Ley MB, Chalasani P, Viscusi RK, et al. Concurrent Capecitabine and Radiation Therapy for High-risk Primary Breast Cancer. Oncomedicine. 2017. doi:10.7150/oncm.17910

BibTeX
@article{Goyal2017,
  author = {Goyal, Uma and Skrepnik, Tijana and Davuluri, Rajayogesh and Ley, Michele B and Chalasani, Pavani and Viscusi, Rebecca K and Lebeau, Lauren G and Livingston, Robert B and Famoso, Justin and Gonzalez, Victor J},
  title = {Concurrent Capecitabine and Radiation Therapy for High-risk Primary Breast Cancer},
  journal = {Oncomedicine},
  year = {2017},
  doi = {10.7150/oncm.17910}
}
Kostenlos starten →